Bruno Gagnon
Corporate Officer/Principal chez OPTHEA LIMITED
Postes actifs de Bruno Gagnon
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OPTHEA LIMITED | Corporate Officer/Principal | 01/07/2022 | - |
Historique de carrière de Bruno Gagnon
Anciens postes connus de Bruno Gagnon
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Directeur des opérations | - | - |
| EIDOS THERAPEUTICS, INC. | Directeur des opérations | - | - |
Formation de Bruno Gagnon
| University of Montréal | Graduate Degree |
| Université Laval | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Canada | 3 |
| Australie | 2 |
Opérationnelle
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| OPTHEA LIMITED | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Eidos Therapeutics, Inc.
 Eidos Therapeutics, Inc. BiotechnologyHealth Technology Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Bruno Gagnon
- Expérience
